Tumor-infiltrating T-lymphocytes (TILs) were identified by specific antibodies for the cell surface markers CD3 and CD8 by immunocytochemistry (Fig. 1b), and quantified by two independent observers blinded to the identity of the samples. This evidence concerns the gene CD8A and neoplasm.